This inventor holds 1 USPTO granted patent. Top assignees: Cerva-Coda, Institut Scientifique De Sante Publique, Université De Mons. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Isabelle Georis: Innovator in Paratuberculosis Diagnosis and Vaccination
Introduction
Isabelle Georis is a notable inventor based in Erpent, Belgium. She has made significant contributions to the field of veterinary medicine, particularly in the diagnosis and vaccination against paratuberculosis. Her innovative work has implications not only for livestock but also for human health.
Latest Patents
Isabelle Georis holds a patent for "Antigens for paratuberculosis diagnosis and vaccination." This invention discloses new antigens of the subspecies, along with antigenic compositions that comprise at least two of these antigens. The patent also includes epitopes, antibodies, or hypervariable fragments thereof, as well as nucleotide sequences coding for them. The invention is aimed at improving diagnosis and vaccination against the subspecies in mammals, particularly in cattle, sheep, and caprines. Furthermore, it explores potential applications in diagnosing and vaccinating against Crohn's disease in humans.
Career Highlights
Throughout her career, Isabelle has worked with various organizations, including Cerva-Coda and Université De Mons. Her experience in these institutions has allowed her to develop her expertise in immunology and veterinary science.
Collaborations
Isabelle has collaborated with notable colleagues such as Ruddy Wattiez and Christiane A J Huygen. These partnerships have contributed to her research and the successful development of her patent.
Conclusion
Isabelle Georis is a pioneering inventor whose work in paratuberculosis diagnosis and vaccination has the potential to impact both veterinary and human medicine. Her contributions are invaluable in advancing the field and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile